SCM
HUMA icon

Sio Capital Management’s Humacyte HUMA Stock Holding History

Sio Capital Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,000,000
Closed -$6.22M – 53
2024
Q1 		$6.22M Buy
+2,000,000
New +$6.73M 1.85% 16
2023
Q1 		– Sell
-49,998
Closed -$20.3K – 47
2022
Q4 		$20.3K Buy
+49,998
New +$152K 0.01% 45

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $23.5B AUM 33.24% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Sio Capital Management's HUMA Position: Q2 2024 in Review

Sio Capital Management sold out of Humacyte (HUMA) in Q2 2024, closing a stake of 2,000,000 shares — an estimated $6.22M sold.

Sio Capital Management first reported a position in HUMA in Q4 2022 and held it in 2 quarters. The position peaked at $6.22M in Q1 2024. 123 funds tracked by Wall St. Rank hold HUMA as of Q2 2024.

  • Sio Capital Management reported no remaining Humacyte position as of Q2 2024 after selling out during the quarter.
  • Sio Capital Management sold 2,000,000 Humacyte shares in Q2 2024, an estimated $6.22M.
  • Sio Capital Management first reported a position in Humacyte in Q4 2022 and held it in 2 quarters.
  • Sio Capital Management's Humacyte position peaked at $6.22M in Q1 2024.
  • 123 funds tracked by Wall St. Rank held Humacyte as of Q2 2024.

Based on Sio Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.